{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T08:21:06Z","timestamp":1773735666050,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jemermed.2021.07.011","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T07:23:13Z","timestamp":1630394593000},"page":"e99-e102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Severe Perampanel Toxicity in a Pediatric Patient With Prolonged Symptoms"],"prefix":"10.1016","volume":"61","author":[{"given":"Garret A.","family":"Winkler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia B.","family":"Minns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allyson A.","family":"Kreshak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2021.07.011_bib0001","unstructured":"Fycoma [Package Insert]. Published online 9\/2020. Accessed February 23, 2021. https:\/\/www.fycompa.com\/-\/media\/Files\/Fycompa\/Fycompa_Prescribing_Information.pdf"},{"key":"10.1016\/j.jemermed.2021.07.011_bib0002","series-title":"FDA-Approved Drugs. U.S. Food and Drug Administration","year":"2021"},{"issue":"12","key":"10.1016\/j.jemermed.2021.07.011_bib0003","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40263-012-0021-2","article-title":"Perampanel: as adjunctive therapy in patients with partial-onset seizures","volume":"26","author":"Plosker","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jemermed.2021.07.011_bib0004","series-title":"Summary of Product Characteristics","year":"2021"},{"issue":"7","key":"10.1016\/j.jemermed.2021.07.011_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2020.04.039","article-title":"Pediatric perampanel poisoning","volume":"38","author":"Qozi","year":"2020","journal-title":"The American Journal of Emergency Medicine"},{"issue":"7","key":"10.1016\/j.jemermed.2021.07.011_bib0006","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/15563650.2017.1422743","article-title":"Perampanel overdose causing a prolonged coma","volume":"56","author":"Li","year":"2018","journal-title":"Clin Toxicol"},{"issue":"2","key":"10.1016\/j.jemermed.2021.07.011_bib0007","doi-asserted-by":"crossref","first-page":"87","DOI":"10.14581\/jer.18014","article-title":"Prolonged stupor in perampanel overdose and pharmacokinetic considerations","volume":"8","author":"Kim","year":"2018","journal-title":"J Epilepsy Res"},{"issue":"11","key":"10.1016\/j.jemermed.2021.07.011_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-232517","article-title":"Prolonged unconsciousness in perampanel overdose","volume":"12","author":"Parsons","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"3","key":"10.1016\/j.jemermed.2021.07.011_bib0009","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.psym.2018.07.002","article-title":"Severe Aggression After Perampanel Overdose: Case Report","volume":"60","author":"Wu","year":"2019","journal-title":"Psychosomatics"},{"issue":"3","key":"10.1016\/j.jemermed.2021.07.011_bib0010","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1684\/epd.2013.0598","article-title":"Clinical course of intoxication with the new anticonvulsant drug perampanel","volume":"15","author":"Hoppner","year":"2013","journal-title":"Epileptic Disord"},{"issue":"2","key":"10.1016\/j.jemermed.2021.07.011_bib0011","first-page":"124","volume":"16","author":"Dean","year":"2020","journal-title":"Prolonged and severe CNS depression and truncal ataxia in an accidental pediatric perampanel ingestion"},{"issue":"1","key":"10.1016\/j.jemermed.2021.07.011_bib0012","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.phrs.2012.12.006","article-title":"Novel treatment options for epilepsy: focus on perampanel","volume":"70","author":"Franco","year":"2013","journal-title":"Pharmacol Res"},{"issue":"11","key":"10.1016\/j.jemermed.2021.07.011_bib0013","first-page":"683","article-title":"Perampanel (Fycompa): A Review of Clinical Efficacy and Safety in Epilepsy","volume":"41","author":"Greenwood","year":"2016","journal-title":"P T"},{"issue":"1","key":"10.1016\/j.jemermed.2021.07.011_bib0014","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40120-013-0012-3","article-title":"Perampanel: what is its place in the management of partial onset epilepsy?","volume":"2","author":"Ledingham","year":"2013","journal-title":"Neurology and therapy"},{"key":"10.1016\/j.jemermed.2021.07.011_bib0015","unstructured":"Perampanel, Serum\/Plasma - NMS Labs. NMS Labs 2021. https:\/\/www.nmslabs.com\/tests\/3433SP (accessed May 27, 2021)."},{"issue":"5","key":"10.1016\/j.jemermed.2021.07.011_bib0016","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.eplepsyres.2014.03.015","article-title":"A multicenter survey of clinical experiences with perampanel in real life in Germany and Austria","volume":"108","author":"Steinhoff","year":"2014","journal-title":"Epilepsy Res"},{"issue":"4","key":"10.1016\/j.jemermed.2021.07.011_bib0017","first-page":"215","article-title":"Add-on perampanel and aggressive behaviour in severe drug-resistant focal epilepsies","volume":"32","author":"Juhl","year":"2017","journal-title":"Funct Neurol"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467921005503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467921005503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:48:41Z","timestamp":1760028521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467921005503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0736467921005503"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2021.07.011","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Severe Perampanel Toxicity in a Pediatric Patient With Prolonged Symptoms","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2021.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}